Cost-Consequence Analysis of Apixaban Versus Rivaroxaban for Managing Patients with Venous Thromboembolism in Saudi Arabia

Background and Objective Direct oral anticoagulants (DOACs) have been proven to be cost-effective for treating various conditions, including venous thromboembolism (VTE). Nevertheless, there are no studies assessing the cost-effectiveness of DOACs for VTE treatment in Saudi Arabia using real-world d...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Abdulaali R. Almutairi PhD, Yazed Alruthia PhD, Majed S. Alyami PharmD, Omar A. Alshaya PharmD, Taif Z. Alanazi PharmD, Sarah I. Al Daghreer PharmD, Ghazwa B. Korayem PharmD, Sarah A. Alrasheed PharmD, Reema A. Alorf PharmD, Omar A. Almohammed PhD
Formato:	Artigo
Idioma:	Inglês
Publicado em:	SAGE Publishing 2025-02-01
coleção:	Clinical and Applied Thrombosis/Hemostasis
Acesso em linha:	https://doi.org/10.1177/10760296251318705
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!